Is it necessary to operate nonmetastatic breast cancer in the elderly?

Czech version

Authors: P. Jandík ¹; J. Mergancová ¹; F. Čečka ¹; B. Melichar ²; J. Dvořák ²; H. Urmínská ³
Authors‘ workplace: Chirurgická klinika přednosta prof. MUDr. Zbyněk Vobořil, DrSc. ¹; Klinika onkologie a radioterapie přednosta doc. MUDr. Jiří Petera, Ph. D. ²; Radiodiagnostická klinika přednosta prof. MUDr. Pavel Eliáš, CSc. Fakultní nemocnice Hradec Králové Ředitel: doc. MUDr. Leoš Heger, CSc. ³
Published in: Prakt. Lék. 2006; 86(6): 333-335
Category: Of different specialties

Overview

The authors presents a group of 52 patients in advanced age with non-metastatic breast cancer. In addition to confirmed hormonally dependent carcinoma, all have had an important co-morbidity. Therefore in all patients, hormonal therapy (HT) by selective aromatase inhibitors was the first choice treatment. Tumor regression was detected in 45 patients (86, 5%), a complete clinical response in 8 (15,5 %). An important therapeutic benefit was noticed, which helped to maintain an adequate quality of life.

Key words:
breast carcinoma in the elderly, selective aromatase inhibitors, primary treatment